<SEC-DOCUMENT>0001104659-23-130004.txt : 20240130
<SEC-HEADER>0001104659-23-130004.hdr.sgml : 20240130
<ACCEPTANCE-DATETIME>20231228141113
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001104659-23-130004
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20231228

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Astria Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001454789
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		75 STATE STREET
		STREET 2:		SUITE 1400
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02109
		BUSINESS PHONE:		617-349-1971

	MAIL ADDRESS:	
		STREET 1:		75 STATE STREET
		STREET 2:		SUITE 1400
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02109

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CATABASIS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20090127
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0">&nbsp;<IMG SRC="tm2332875d4_correspimg001.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0">&nbsp;<IMG SRC="tm2332875d4_correspimg002.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">December&nbsp;28, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>By Electronic Submission</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Division of Corporation Finance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Office of Life Sciences</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100 F Street, N.E.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Washington, DC 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Cindy Polynice and Laura Crotty</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">Re:</TD><TD>Astria Therapeutics,&nbsp;Inc.<BR>
Registration Statement on Form&nbsp;S-3<BR>
Filed December&nbsp;15, 2023<BR>
File No.&nbsp;333-276057</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On behalf of Astria Therapeutics,&nbsp;Inc. (the &ldquo;<U>Company</U>&rdquo;),
filed herewith is Amendment No.&nbsp;1 (&ldquo;<U>Amendment No.&nbsp;1</U>&rdquo;) to the Registration Statement referenced above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Amendment No.&nbsp;1 is being submitted in response to a comment contained
in a letter, dated December&nbsp;27, 2023 (the &ldquo;<U>Letter</U>&rdquo;), from Cindy Polynice and Laura Crotty of the Staff (the &ldquo;<U>Staff</U>&rdquo;)
of the Securities and Exchange Commission to Jill Milne, the Company&rsquo;s President and Chief Executive Officer. For convenient reference,
we have set forth below in italics the Staff&rsquo;s comment set forth in the Letter and have keyed the Company&rsquo;s response to the
numbering of the comment and the heading used in the Letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Registration Statement on Form&nbsp;S-3 filed December&nbsp;15,
2023</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>General</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5%">1.</TD><TD STYLE="width: 95%"><I>In relation to the warrant share prospectus, we note that the Pre-Funded Warrants and Common Stock Warrants were issued and sold
in an underwritten offering in October&nbsp;of 2023. We also note that both the Pre-Funded Warrants and Common Stock Warrants were exercisable
from the date of issuance. As set out in Securities Act Sections C&amp;DI Question 103.04, where the offer and sale of convertible securities
or warrants are being registered under the Securities Act and such securities are convertible or exercisable within one year, the underlying
securities should be registered at the same time because an offering of both the overlying security and underlying security is deemed
to be taking place. With this in mind, please explain your rationale for including the warrant share prospectus as part of this registration
statement.</I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<IMG SRC="tm2332875d4_correspimg003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">December&nbsp;28, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page&nbsp;2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="RIGHT" STYLE="font: 10pt Times New Roman, Times, Serif; width: 95%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 10%"><B>Response:</B></TD>
    <TD STYLE="width: 90%">
    In
response to the Staff&rsquo;s comment, the Company advises the Staff that the offer and sale of the Pre-Funded Warrants and the Common
Stock Warrants (collectively, the &ldquo;<U>Warrants</U>&rdquo;) and the shares of common stock issuable upon exercise of the Warrants
(the &ldquo;<U>Warrant Shares</U>&rdquo;) were originally registered under the Company&rsquo;s prior Registration Statement on Form&nbsp;S-3
(File No.&nbsp;333-271848) (the &ldquo;<U>Prior S-3</U>&rdquo;). The offer and sale of the Warrants was completed in connection with
the Company&rsquo;s underwritten offering thereof in October&nbsp;2023 and the offer and sale of the Warrant Shares has continued pursuant
to the outstanding Warrants on an ongoing basis since then. The Company desires to register under the new Registration Statement on Form&nbsp;S-3
(File No.&nbsp;333-276057) the offer and sale of the Warrant Shares that remain unsold as of the date hereof (which amounts to all of
the Warrant Shares, as none of the Warrants have been exercised to date) in accordance with Rule&nbsp;415(a)(6), and in connection therewith
to terminate the registration of the offer and sale of the Warrant Shares under the Prior S-3. The Company further advises the Staff
that the Company has added disclosure to the cover page&nbsp;of the warrant share prospectus included in Amendment No.&nbsp;1 regarding
the prior registration of the offer and sale of the Warrants and the Warrant Shares under the Prior S-3.<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P></TD></TR>
  </TABLE><BR STYLE="clear: both">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If you have any further questions or comments, or if you require any
additional information, please contact the undersigned by telephone at (617) 526-6633 or facsimile at (617) 526-5000. Thank you for your
assistance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; width: 50%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Rosemary G. Reilly</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rosemary
    G. Reilly</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 27pt">cc:</TD><TD>Jill C. Milne, Chief Executive Officer, Astria Therapeutics,&nbsp;Inc.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm2332875d4_correspimg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2332875d4_correspimg001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  9 'L# 2(  A$! Q$!_\0
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JHQ=22G._('<D\5>&B^(9]TMSK[6\K,3Y5I&?+09X R,],?CFNLHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm2332875d4_correspimg002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2332875d4_correspimg002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  Q &<# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#WTL ,D@#W
MJG=ZG;6,]K#,[A[E_+C 0GGW/;\:K>(-.N-3TF6VM;I[>1\=-O/(ZY!IUY83
MS6]G&)3*\5Q'*TDF 2 <GH,4 37^I0Z=%$TBR/),_EQQQ+N9S@G@?0$U"NN6
M9^Q9$Z->L5B1H6!!&<[N/EZ=ZK:_I;:C-87 @^TK:2.S6YDV>8&4CZ<<'!J.
MRTF^CTK3()F!EMKKSG!<ML3YL(#WP"!^% %U]8ACU2*P>WNEDF<JDAB^1B!D
M\^F!3Y]5BAU$6*PW$TVU7;RH\A Q(!)_ _E4:V4TGB.2_GV^1# (;8 YY)S(
MQ].BC\*S-=T:XO-1>>ULHC/)%&B7WG%6@*L3G;WZ\8Z]#Q0!?_X2*P2\:"3S
MHE!D F>(B-C&,N ?8 _D:GT[5(M1+A(;J(JJN//B*[E/0C\OKZUB7>DZEK&H
M:C]O@$<4D$MK9NLP(B5A@OC&=S?H./6K6@:9=65]-*UL+.V,,<?D";S/,D7.
M9/;C ]3CF@"VOB"Q,\J$3K"GF9N3&?*)3[X#>V#^1Q4:>)K)X'E\JY1T:-!
M\1$C&3[F%]^?R.<8K"_X1.[VM90QB!<7(DO/.SYZ2;MBE/8L#[;>.M63I6KW
M%T-4DM8X[F!X-EN)@?,$8D#<]!GS3CZ<T :DOBC3X[>*;$[+(C2,$B),2H<,
M7';!X-7)M6L;>5HYIU145&+N<*-YPO/J2*YIM"U2**:6.WBDFOH)X9HS)@0-
M+(6!SW #$''I4]YH4V;Z%+=;E'AM'C\S&&:)N5YZ$@?K0!TMM=QW7G^6"6AE
M,3@]B/\ ZQ!_&BJ6DVTT5QJ=S(AC^TW6]%;L BKG\<&B@#59@H+,0 .YJE>Z
ME!8SVL,HDWW,@BCV(2,^Y["J_B#3)]5TJ2VM[J2"1L8*D8/(ZY!IUUI\TEK9
MQ+,9&@N(Y6>7JP!R>@ZT 2WVH1Z>D6Z.666:3RXHH@"S-@GO@=%)R:B77;8_
M8=T=RC7K%(U>$@J1G.[TZ56U_2C?RV-Q]F2Z%I(SFWD?:) 5(^G'!YJ.RTB[
MBTO3+>1E,EM=><PW$A$^;"@]\ @?A0!=;64BU6&PDL[I7G9EBD*C:VT9)SG.
M/PI\^K)'J7V!+:YGG"+(YB4;4#$@9)(]#^5,2PF?Q!)J$S+Y4< AMD!Z9.7)
M]SA!^%9>N:+<7NH/);6=L998HXUO2Y$EOM8G.._7C&.X/% %YO$-G%<O#,ES
M#&/,"SO'A',8RV._ ![8.#C-6-/U1-1+!;6Z@8*KKY\6T,IZ$'\.G4=Q6+<Z
M/J.JW^I?;X56.6WEMK1XYLB&-AC=MQG>W<]@ !WJSH6DW-C?3SM;Q6<+P1Q?
M9XGW!W7.9#^! ]3CF@"[#KMO-]IE\FX2VM_,\RY=1Y?[LD-CG/8]NU0)XFM&
MA9S;W:3!HU6W>/$DADY7 SCG![\8.<8K*F\,W%Q/<Q1VMO9QRBY\V>*0DW'F
MYQD=1@G)]QQUI[:1J\]P-3DMX$NH7@\NW$N0XC#AOFQQGS#CZ"@#0D\4V$5O
M',(KE@T<DKJL7S1*AVN6';!XXS4^H:_8Z>D[NV\Q)&_#  [SA1DG&3_*L-M
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H15&,87!_E10!I4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tm2332875d4_correspimg003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2332875d4_correspimg003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  F M # 2(  A$! Q$!_\0
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MMNT:LNU1]^+!X$O7![Y%:=QIZ75MIPMQJ[6T]^CSQRB2(QIY3 C  (&<9]Z
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M.G-:?AW3IK8W]]=*T<]_<&8HQY50,*#CC.!S0!T%%%% !1110 4444 %%%%
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MBWD"PR2DD$29P9.F=H! '?CFGW.L7\MM+$IA!C@E:22(',CJP'[OG@'/Y\4
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>)_OLL8!;OSZU,EO"DKS)$JR28WL!RV.F3110!__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
